Cargando…
Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms
Spinal cord injury (SCI) has a major impact on affected patients due to its pathological consequences and absence of capacity for self-repair. Currently available therapies are unable to restore lost neural functions. Thus, there is a pressing need to develop novel treatments that will promote funct...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620694/ https://www.ncbi.nlm.nih.gov/pubmed/34831412 http://dx.doi.org/10.3390/cells10113189 |
_version_ | 1784605282229288960 |
---|---|
author | Zarepour, Atefeh Hooshmand, Sara Gökmen, Aylin Zarrabi, Ali Mostafavi, Ebrahim |
author_facet | Zarepour, Atefeh Hooshmand, Sara Gökmen, Aylin Zarrabi, Ali Mostafavi, Ebrahim |
author_sort | Zarepour, Atefeh |
collection | PubMed |
description | Spinal cord injury (SCI) has a major impact on affected patients due to its pathological consequences and absence of capacity for self-repair. Currently available therapies are unable to restore lost neural functions. Thus, there is a pressing need to develop novel treatments that will promote functional repair after SCI. Several experimental approaches have been explored to tackle SCI, including the combination of stem cells and 3D bioprinting. Implanted multipotent stem cells with self-renewing capacity and the ability to differentiate to a diversity of cell types are promising candidates for replacing dead cells in injured sites and restoring disrupted neural circuits. However, implanted stem cells need protection from the inflammatory agents in the injured area and support to guide them to appropriate differentiation. Not only are 3D bioprinted scaffolds able to protect stem cells, but they can also promote their differentiation and functional integration at the site of injury. In this review, we showcase some recent advances in the use of stem cells for the treatment of SCI, different types of 3D bioprinting methods, and the combined application of stem cells and 3D bioprinting technique for effective repair of SCI. |
format | Online Article Text |
id | pubmed-8620694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86206942021-11-27 Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms Zarepour, Atefeh Hooshmand, Sara Gökmen, Aylin Zarrabi, Ali Mostafavi, Ebrahim Cells Review Spinal cord injury (SCI) has a major impact on affected patients due to its pathological consequences and absence of capacity for self-repair. Currently available therapies are unable to restore lost neural functions. Thus, there is a pressing need to develop novel treatments that will promote functional repair after SCI. Several experimental approaches have been explored to tackle SCI, including the combination of stem cells and 3D bioprinting. Implanted multipotent stem cells with self-renewing capacity and the ability to differentiate to a diversity of cell types are promising candidates for replacing dead cells in injured sites and restoring disrupted neural circuits. However, implanted stem cells need protection from the inflammatory agents in the injured area and support to guide them to appropriate differentiation. Not only are 3D bioprinted scaffolds able to protect stem cells, but they can also promote their differentiation and functional integration at the site of injury. In this review, we showcase some recent advances in the use of stem cells for the treatment of SCI, different types of 3D bioprinting methods, and the combined application of stem cells and 3D bioprinting technique for effective repair of SCI. MDPI 2021-11-16 /pmc/articles/PMC8620694/ /pubmed/34831412 http://dx.doi.org/10.3390/cells10113189 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Zarepour, Atefeh Hooshmand, Sara Gökmen, Aylin Zarrabi, Ali Mostafavi, Ebrahim Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms |
title | Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms |
title_full | Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms |
title_fullStr | Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms |
title_full_unstemmed | Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms |
title_short | Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms |
title_sort | spinal cord injury management through the combination of stem cells and implantable 3d bioprinted platforms |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620694/ https://www.ncbi.nlm.nih.gov/pubmed/34831412 http://dx.doi.org/10.3390/cells10113189 |
work_keys_str_mv | AT zarepouratefeh spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms AT hooshmandsara spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms AT gokmenaylin spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms AT zarrabiali spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms AT mostafaviebrahim spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms |